Randomized phase II trial of neoadjuvant gemcitabinecisplatin (GemCis) with or without durvalumab (D) for localized biliary tract cancers (BTC): Final clinical and biomarker analysis of the DEBATE study

Yoo, C.; Kim, H-d.; Kim, C. Y.; Park, J. O.; Jeong, H.; Kim, K-P.; Hong, J. Y.; Shin, S. H.; Song, T. J.; Oh, D.; Lee, W.; Lee, J. H.; Hwang, D. W.; Lee, J. S.

doi:10.1016/j.annonc.2025.10.105

상세 보기

Randomized phase II trial of neoadjuvant gemcitabinecisplatin (GemCis) with or without durvalumab (D) for localized biliary tract cancers (BTC): Final clinical and biomarker analysis of the DEBATE study

Yoo, C.;
Kim, H-d.;
Kim, C. Y.;
Park, J. O.;
Jeong, H.;
... Hong, J. Y.;
... Shin, S. H.;
외 7명

Citations

WEB OF SCIENCE

0

제목: Randomized phase II trial of neoadjuvant gemcitabinecisplatin (GemCis) with or without durvalumab (D) for localized biliary tract cancers (BTC): Final clinical and biomarker analysis of the DEBATE study

저자: Yoo, C.; Kim, H-d.; Kim, C. Y.; Park, J. O.; Jeong, H.; Kim, K-P.; Hong, J. Y.; Shin, S. H.; Song, T. J.; Oh, D.; Lee, W.; Lee, J. H.; Hwang, D. W.; Lee, J. S.

DOI: 10.1016/j.annonc.2025.10.105

발행일: 2025-12

유형: Meeting Abstract

저널명: Annals of Oncology

권: 36

@

상세 보기